Madrigal Pharmaceuticals Inc (MDGL)
329.24
+12.15
(+3.83%)
USD |
NASDAQ |
Nov 21, 16:00
Madrigal Pharmaceuticals Total Liabilities (Quarterly): 296.11M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 296.11M |
| June 30, 2024 | 242.67M |
| March 31, 2024 | 231.52M |
| December 31, 2023 | 235.21M |
| September 30, 2023 | 215.72M |
| June 30, 2023 | 198.96M |
| March 31, 2023 | 182.31M |
| December 31, 2022 | 165.18M |
| September 30, 2022 | 147.97M |
| June 30, 2022 | 132.86M |
| March 31, 2022 | 76.92M |
| December 31, 2021 | 77.22M |
| September 30, 2021 | 69.82M |
| June 30, 2021 | 57.30M |
| March 31, 2021 | 49.18M |
| December 31, 2020 | 47.02M |
| September 30, 2020 | 49.91M |
| June 30, 2020 | 45.47M |
| March 31, 2020 | 25.98M |
| December 31, 2019 | 25.49M |
| September 30, 2019 | 15.90M |
| June 30, 2019 | 12.84M |
| March 31, 2019 | 11.05M |
| December 31, 2018 | 8.444M |
| September 30, 2018 | 6.642M |
| Date | Value |
|---|---|
| June 30, 2018 | 5.436M |
| March 31, 2018 | 6.294M |
| December 31, 2017 | 10.05M |
| September 30, 2017 | 8.523M |
| June 30, 2017 | 6.436M |
| March 31, 2017 | 5.906M |
| December 31, 2016 | 4.80M |
| September 30, 2016 | 3.915M |
| June 30, 2016 | 3.364M |
| March 31, 2016 | 8.639M |
| December 31, 2015 | 49.28M |
| September 30, 2015 | 30.64M |
| June 30, 2015 | 32.56M |
| March 31, 2015 | 33.25M |
| December 31, 2014 | 35.54M |
| September 30, 2014 | 39.93M |
| June 30, 2014 | 41.95M |
| March 31, 2014 | 43.96M |
| December 31, 2013 | 46.11M |
| September 30, 2013 | 42.05M |
| June 30, 2013 | 38.49M |
| March 31, 2013 | 37.10M |
| December 31, 2012 | 27.95M |
| September 30, 2012 | 25.42M |
| June 30, 2012 | 26.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.49M
Minimum
Dec 2019
296.11M
Maximum
Sep 2024
128.64M
Average
105.04M
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 145.42M |
| ADMA Biologics Inc | 158.73M |
| 89bio Inc | 80.20M |
| Sarepta Therapeutics Inc | 2.379B |
| Matinas BioPharma Holdings Inc | 4.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.073B |
| Shareholders Equity (Quarterly) | 777.16M |
| Debt to Equity Ratio | 0.1507 |
| Current Ratio | 5.981 |
| Net Debt Paydown Yield | -0.08% |